Skip to main content
TipRanks
Go Ultimate75% OFF

Fate Therapeutics (F6T) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

F6T Analyst Ratings

Moderate Buy
7Ratings
3Buy4Hold0Sell
Based on 7 analysts giving stock ratings to Fate Therapeutics in the past 3 months

F6T Stock 12 Month Forecast

€5.08▲(203.02% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for Fate Therapeutics in the last 3 months. The average price target is EUR 5.08 with a high forecast of EUR 7.14 and a low forecast of EUR 2.23. The average price target represents a 203.02% change from the last price of EUR 1.68.
Highest Price Target€7.14Average Price Target€5.08Lowest Price Target€2.23

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:F6T
Price TargetArticle
Wells Fargo€3.12→€2.68hold59.48%UpsideAssigned11/06/26
Bank of America Securities€1.96→€2.23hold32.90%UpsideReiterated11/06/26
Piper Sandler€7.14buy325.29%UpsideReiterated11/06/26
Wedbush€6.24buy272.13%UpsideReiterated11/06/26
Needham―hold―Reiterated10/05/26
Mizuho Securities Analyst forecast on DE:F6TUnknown AnalystNot RankedMizuho Securities€7.14buy325.29%UpsideReiterated08/17/26
TD Cowen―hold―Reiterated08/13/26
H.C. Wainwright€6.24buy272.13%UpsideReiterated07/09/26
Jefferies€3.57buy112.65%UpsideInitiated05/19/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PTGXProtagonist Therapeutics
ESTAEstablishment Labs Holdings
MDWDMediwound
IMUXImmunic
OVIDOvid Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Fate Therapeutics

3 Months
Martin Fan
Martin FanWedbush
Success Rate2/4 ratings generated profit
50%
Average Return
+11.47%

Copying Martin Fan's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +11.47% per trade.

1 Year
Martin Fan
Martin FanWedbush
Success Rate2/4 ratings generated profit
50%
Average Return
+26.63%

Copying Martin Fan's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +26.63% per trade.

2 Years
Martin Fan
Martin FanWedbush
Success Rate2/4 ratings generated profit
50%
Average Return
+23.08%

Copying Martin Fan's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +23.08% per trade.

F6T Analyst Recommendation Trends

05101520Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for F6T
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy119465
Buy00000
Hold65443
Sell00000
Strong Sell00000
total17148108

In the current month, F6T has received 5 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. F6T average Analyst price target in the past 3 months is 5.08.

F6T Financial Forecast

€-2€-1.5€-1€-0.5€0Q1 2026Q3 2026Q4 2026
High€-0.13
Consensus€-0.23
Low€-0.30

F6T Earnings Forecast

Next quarter’s earnings estimate for F6T is -EUR 0.23 with a range of -EUR 0.30 to -EUR 0.13. The previous quarter’s EPS was -EUR 0.22. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

€-1€3.4M€6.7M€10.1M€13.4MQ1 2026Q3 2026Q4 2026
High€13.4M
Consensus€1.98M
Low€0.00

F6T Sales Forecast

Next quarter’s sales forecast for F6T is EUR 1.98M with a range of EUR 0 to EUR 13.43M. The previous quarter’s sales results were EUR 0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

F6T Stock Forecast FAQ

What is DE:F6T’s average 12-month price target, according to analysts?
Based on analyst ratings, Fate Therapeutics’s 12-month average price target is €5.08.
What is DE:F6T’s upside potential, based on the analysts’ average price target?
Fate Therapeutics has 203.02% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Fate Therapeutics a Buy, Sell or Hold?
Fate Therapeutics has a consensus rating of Moderate Buy, which is based on 3 buy ratings, 4 hold ratings and 0 sell ratings.
What is Fate Therapeutics’s share price target?
The average share price target for Fate Therapeutics is €5.08. This is based on 7 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €7.14, and the lowest forecast is €2.23. The average share price target represents a 203.02% increase from the current price of €1.678.
What do analysts say about Fate Therapeutics?
Fate Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 7 Wall Street analysts.
How can I buy shares of Fate Therapeutics?
To buy shares of DE:F6T, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.